biote Corp.(BTMD)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

biote Corp. (BTMD) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores BTMD at 39.6/100 on a 32-signal composite quality model, placing it at rank #2,141 of 2,962 stocks — the bottom half of the AI-ranked universe. BTMD scores in the top quartile across earnings quality (92.8). Areas of concern include institutional flow (3.5) and revenue growth (19.0), which score below median versus the broader universe. Shareholder dilution risk is elevated at 25.9/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), biote Corp. reports quarterly revenue of $44.2M, net income of $-6.6M, free cash flow of $-3.7M. Top institutional holders of BTMD by reported 13-F value include 325 CAPITAL, Bandera Partners, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. BTMD trades on the Nasdaq exchange and files with the SEC under CIK 1819253. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BTMD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for biote Corp. directly from SEC EDGAR.